Together, these findings suggest that SLC25A1 plays an important role in the dynamic metabolic switch between fatty acid synthesis and OXPHOS to promote tumor growth and maintain energy balance during energy stress (Fig. 7), implying that SLC25A1 could be a suitable target for metabolism-based therapeutic strategies in CRC. This evidence concerns the gene SLC25A1 and neoplasm.